| Pharmaceutical active ingredients: |
| Cysteamine Bitartrate |
| Available forms, composition and doses of Cystagon: |
| Capsules; Oral; Cysteamine Bitartrate 150 mgCapsules; Oral; Cysteamine Bitartrate 50 mg |
| Cystagon medical category: |
| Human:Amino acid cysteine derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Orphan PharmaceuticalMylan |
| Related documents and information about Cystagon: |
| Cystagon prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Antizol | Fomepizole | Orphan Pharmaceutical; IDIS World Medicines; Medisource; Paladin Laboratories; Tzamal Pharma |
| Betapred | Betamethasone Sodium Phosphate | Orphan Pharmaceutical |
| Carbaglu | Carglumic Acid | Orphan Pharmaceutical |
| Cystadan | Betaine Anhydrous | Orphan Pharmaceutical; Tzamal Pharma |
| Cystadane | Betaine Anhydrous | Orphan Pharmaceutical; Accredo Health Group; Rare Disease Therapeutics |
| Fosrenol | Lanthanum (Lanthanum Carbonate Hydrate) | Orphan Pharmaceutical; DSM Pharmaceuticals; Fahrenheit; Hind Wing; Invida; Opopharma; Shire; Zuellig Pharma |
| Normosang | Hemin Human | Orphan Pharmaceutical; Leiras; Stauffacher Apotheke |
| Orfadin | Nitisinone | Orphan Pharmaceutical; Apoteket Produktion & Laboratorier; Rare Disease Therapeutics |
| Pedea | Ibuprofen | Orphan Pharmaceutical; Merckle; Nycomed |
| Remodulin | Treprostinil Sodium | Orphan Pharmaceutical; Andromaco Laboratorios; Bioprojet Pharma; OrPha Swiss; Rafa Laboratories; United Therapeutics Corporation |